COMS

Un listing de conférences scientifiques et techniques

Accueil | Logiciel de gestion de conférence | Calendrier des conférences | Annonces publicitaires | Nous contacter | Qui nous sommes
Deutsch Français English
Vous êtes ici: AccueilCalendrier des conférencesSoins de santé → Pharmacologie et développement des médicaments - États-Unis
2nd annual Lyophilisation conference on 7-8 July 2014, London

Logiciel de gestion de conférences

Notre système de gestion de conférences en ligne (COMS) vous permet de:

  • gérer l'organisation de la conférence en ligne
  • gérer les inscriptions
  • gérer les paiements
  • gérer les soumissions de présentations
  • gérer la procédure de revue
  • sélectionner les présentations
  • produire le livre des résumés

Pour en savoir plus ...

Conférences - Pharmacologie et développement des médicaments - États-Unis

Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Les organisateurs peuvent soumettre une réunion ou une conférence pour inclusion dans nos listes, et ceci gratuitement.

1.Drug Discovery Chemistry 2014
 Dates 23 Avr 2014 → 25 Avr 2014
[ID=583952] Haut de la page
 LieuSan Diego, Californie, États-Unis
 Résumé Drug Discovery Chemistry is the leading conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to move between concurrent meetings and create a unique program according to personal interests. New this year is Epigenetic Inhibitor Discovery which nicely complements the most popular topics from previous years: Anti-Inflammatories, Protein-Protein Interactions, Macrocyclics and Constrained Peptides, Fragment-Based Drug Discovery, and Kinase Inhibitor Chemistry.
 Sujets drug discovery, chemistry, medicinal chemistry, kinase inhibitors, protein-protein interactions, pharmaceuticals, biotechnology, small molecule, anti-inflammatories, epigenetics
 Page web http://www.drugdiscoverychemistry.com
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
 Sujets apparentés Biochimie et chimie médicale, toxicologie
  
2.Biomarkers & Diagnostics World Congress
 Dates 30 Avr 2014 → 02 Mai 2014
[ID=609075] Haut de la page
 LieuPhiladelphia, PA, États-Unis
 Résumé The World Congress will continue offering a comprehensive coverage of biomarkers in drug development, including translational biomarkers, patient selection and drug-diagnostic co-development. The Executive Summit on Companion Diagnostics is designed to bring together drug development and diagnostics leaders to brainstorm strategies for Rx-Dx co-development, including reimbursement, regulatory, and technology/implementation strategies. A new track on Laboratory-Developed Tests will follow the Clinical Biomarker Assay Development track, for complete coverage on biomarker assay development technologies, regulation, and clinical utility. Finally, a new track on Mutation Analysis for Clinical Biomarkers and Diagnostics will cover the recent research and technologies related to genomic analysis to guide clinical decision making. Please join us for comprehensive scientific coverage and unparallel networking opportunities at the Tenth Anniversary Congress!
 Sujets Biomarker, Clinical Biomarkers, translational medicine, personalized medicine, Companion diagnostics, Biomarker assay development and validation, Oncology drug development, safety, patient selection, Biomarker consortia, Protein Biomarkers, Molecular Diagnostics, Partnering Strategies, Drug Safety, Tranlsational Biomarkers, Circulating Tumor Cells, Biomarker Assay Development
 Page web http://www.biomarkerworldcongress.com/
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
  
3.2-day In-person Seminar on “The A to Z's of Microbial Control, Monitoring and validation of Pharmaceutical Water Systems” in San Diego
 Dates 01 Mai 2014 → 02 Mai 2014
[ID=613984] Haut de la page
 LieuSao Paulo, États-Unis
 Résumé This course is designed to provide a microbiology-focused education about all aspects of water systems and how biofilm manages to thrive there. Prior microbiological education or training, though a plus, is not a requirement because engineers and other non-biologists also need this training if they are involved with any aspect of water systems. The instructor will provide the necessary background needed to understand this very important subject matter. This understanding is essential to the proper design, validation, operation, monitoring, maintenance, troubleshooting, and excursion investigations of a high purity water system. Without this understanding, water system control consists of a set of rules that often don't work and can cause very costly system downtime or even product recalls, and leaves the user without a clue as to what went wrong or how to effectively fix it so it doesn't recur.
 Sujets Pharmaceutical training, compliance training, FDA training, pharmaceutical water systems, Microbiological Quality, regulatory training, regulatory and compliance
 Page web http://bit.ly/1a7xdLC
 Contact John Robinson ; Tél.: [18004479407]; Email.: support@globalcompliancepanel.com
  
4.UMASS Amherst Models to Medicine: Challenges and Opportunities, Kick-Off Symposium
 Date de début02 Mai 2014
[ID=616646] Haut de la page
 LieuAmherst, MA, États-Unis
 Résumé The new Models to Medicine Center of the recently launched Institute for Applied Life Sciences at the University of Massachusetts Amherst is hosting a kick-off symposium on “Models to Medicine: Challenges and Opportunities,” Friday, May 2, 2014. The symposium talks will describe exciting basic biomedical research pursuits that have been translated into therapeutic applications. The day will begin at 11:00 am with a poster session that showcases “Models-to-Medicine” research activities at UMass Amherst, to be held in the new Life Science Laboratories. Box lunches will be available (must be reserved in advance). Next, we will move to the Student Union Ballroom to begin the formal symposium with a panel discussion on the topic of challenges and opportunities arising in translation of basic research outcomes into therapeutic applications, followed by four talks that illustrate this theme. The day will end with a reception to which all attendees are invited. This symposium offers attendees a unique opportunity to hear presentations from leading researchers and to network with academic and industrial researchers from the New England area.
 Sujets Therapeutic applications of basic research outcomes.
 Page web http://www.umass.edu/m2msymposium
 Contact Sarah Loomis; Email.: sloomis@umass.edu
 Sujets apparentés Biologie moléculaire; Génomique et bio-informatique
  
5.Biologics Formulation and Delivery Summit
 Dates 05 Mai 2014 → 07 Mai 2014
[ID=609040] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé Advances in molecular biology and biotechnology have allowed for the large-scale production of effective and potent biotherapeutic drugs. Major research issues in protein/peptide delivery include the stabilization of proteins in delivery devices and the design of appropriate target-specific carriers. CHI's Inaugural Biologics Formulation and Delivery Summit will provide a forum for focused discussions on current challenges and opportunities in delivery of biotherapeutics. This multi-track summit will discuss various formulation and device-based approaches for designing physiologically relevant, patient friendly, targeted biologics products.
 Sujets biologics, formulation, drug delivery, formulation development; delivery of biologics, biotherapeutic drugs, biologics delivery
 Page web http://www.healthtech.com/Biologics-Delivery
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
  
6.PEGS: The Essential Protein Engineering Summit
 Dates 05 Mai 2014 → 09 Mai 2014
[ID=609041] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé Over 1,600 participants will gather in Boston’s vibrant seaport district for open forum discussions and collaboration at CHI’s flagship biologics event “PEGS the essential protein engineering summit”. The continued success of PEGS is driven by the growth in biologics worldwide, the quality of scientific programming presented and valuable networking opportunities. 2014 event features Include 1,600+ participants, 20 conferences, 14 short courses, 375+ presentations, 100+ exhibitors, and 175+ posters.
 Sujets protein, protein engineering, protein aggregation, protein purification, protein therapeutics, oncology, therapeutic, expression, bioprocessing, antibodies, antibody, antibody-drug conjugates, biologics, phage, yeast, bispecific antibodies, cancer, cancer therapeutics, autoimmune disease, t-cell, peptide, pk/pd, immunogenicity, adc, peptide
 Page web http://www.pegsummit.com/
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
  
7.Cancer Drug Research & Development Conference — Cancer Drug Research & Development Conference
 Dates 06 Mai 2014 → 07 Mai 2014
[ID=589186] Haut de la page
 LieuBerlin, États-Unis
 Résumé We invite you to join us at GTC's Inaugural Cancer Drug Research & Development Conference on May 6-7, 2014 in Berlin, Germany.
 Sujets Drug Programs, Cancer Targets, Kinase Inhibitors, Drug Resistance, Metabolic Pathways
 Page web https://www.gtcbio.com/conference/cancer-drug-research-development-overview
 Contact Tél.: [6262566405]; Email.: infogtcbio@gtcbio.com
 Sujets apparentés Cancérologie
  
8.11th Annual Mastering Medicinal Chemistry
 Dates 21 Mai 2014 → 22 Mai 2014
[ID=609114] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé Senior executives and industry thought leaders from Pfizer, Roche, Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, AbbVie, AstraZeneca and many more will participate in this year’s program with inspiring discussions on the future role of medicinal chemistry and its contribution to improved drug discovery rates. Senior level chemists from leading life science companies will also discuss how kinetics and residence time, targeted tissue delivery, and allosteric inhibitors enhance profiles or modulate difficult targets. Network and share case studies on difficult targets with industry leading chemists and senior thought leaders during panel discussions, guided roundtable discussions and dedicated exhibit hall hours.
 Sujets medicinal chemistry, chemistry, drug discovery, kinetics, tissue delivery, allosteric inhibitors, small molecules, pharma, macrocycles, kinase inhibitors, drug design, ADCs, antibody-drug conjugates, allosteric modulator
 Page web http://www.healthtech.com/Medicinal-Chemistry
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
  
9.Structure-Based Drug Design
 Dates 21 Mai 2014 → 22 Mai 2014
[ID=609091] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé Experimental methods such as X-ray crystallography, NMR, and computational chemistry techniques have led to a better understanding and larger knowledge base of 3-dimensional structures and binding events, encouraging rapid development of structure-based drug design. Cambridge Healthtech Institute’s Fourteenth Annual Structure-Based Drug Design event will showcase informative, high-quality case studies, innovative techniques, and strategies to move from computation to experiment, and finally, to drug. Top scientists from pharma and biotech will address how they are hitting epigenetic targets, provide updates on the newest wave of GPCRs and other membrane proteins, and discuss the latest in fragment-based drug design. Attendees will return to their organizations with fresh perspectives and new ideas to maximize productivity and increase successes in drug discovery.
 Sujets drug design, structure-based drug design, structure-based design, computational methods, computational chemistry, ISCB, medicinal chemistry, computational technology for drug discovery, structural geonomics, molecular dynamics simulation, fragment-based drug discovery, structure-based approaches, virtual screening, fragment-based design
 Page web http://www.healthtech.com/structure-based-drug-design
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
  
10.World Pharma Congress
 Dates 21 Mai 2014 → 23 Mai 2014
[ID=609115] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé After spending 12 years in Philadelphia the World Pharma Congress is moving to Boston, which is buzzing with new findings and technologies that can potentially revolutionize the way in which traditional preclinical drug discovery is done. World Pharma Congress 2014 will provide a forum for scientists and clinicians to meet to exchange ideas and launch collaborations - here are some reasons why you don't want to miss joining us in the Pharma Hub of Boston!
 Sujets pharma, cardiotoxicity, pain, targeting pain, preclinical models, oncology, molecular imaging, imaging, drug safety, neurotoxicity, cardiotoxicity, hepatotoxicity, animal models of pain, biologics, animal model, drug discovery, Parkinson's Disease, ADME, cancer, formulation, drug delivery
 Page web http://www.worldpharmacongress.com/
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
  
11.GPCR — GPCR Structure, Function and Drug Discovery Conference
 Dates 22 Mai 2014 → 23 Mai 2014
[ID=607225] Haut de la page
 LieuCambridge, MA, États-Unis
 Résumé The GPCR conference seeks to provide a forum for researchers from both industry and academia to exchange complimentary perspectives on the latest discovery. We will cover topics such as biased signaling, novel ligands, X-ray crystallography, and many more. Join us to discuss the future of drug discovery and the role of GPCRs!
 Sujets biased signaling, novel ligands, X-ray crystallography
 Page web http://www.gtcbio.com/conference/gpcr-overview?utm_source=gpcrposting&utm_medium=website&utm_campaign=gpcr2014
 Contact Kristen Starkey ; Tél.: [((626-256-6405))]; Email.: kristen.starkey@gtcbio.com
  
12.Property-Based Drug Design
 Dates 22 Mai 2014 → 23 Mai 2014
[ID=609178] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé One of the most challenging aspects of drug discovery remaining is the identification of new molecular entities (NMEs) with the desirable physicochemical properties and absorption, distribution, metabolism, and excretion (ADME) profiles that can be formulated into safe and efficacious drug products. The third annual Property-Based Drug Design conference will bring together leading experts from industry and academia to discuss advanced tools and technologies being used for better understanding of physicochemical and bio-physical properties and how the new understanding is applied to the drug discovery processes and pharmaceutical development.
 Sujets drug design, pharma, pharmaceutical, drug discovery, new molecular entity, NME, physicochemical, drug formulation, high-throughput screening
 Page web http://www.healthtech.com/Property-Based-Drug-Design
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
  
13.Chemical Biology for Target Validation
 Dates 22 Mai 2014 → 23 Mai 2014
[ID=609166] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé Small molecule drug discovery has approached a critical junction where the rigorous pre-clinical validation and prioritizing of novel targets is of utmost importance. Challenged with thinning development pipelines and significant losses in revenue, greater emphasis is being placed on the stringent selection and validation of targets and candidate molecules to increase success and reduce attrition rates in phase II trials. In response to this challenge, a synergy between drug discovery and chemical biology is emerging as a vital component to providing adequate confidence before launching full discovery programs. The development and utilization of high-quality chemical probes in combination with disease-relevant phenotypic systems provides a powerful approach to obtain a deeper interrogation of target-phenotype relationships - ultimately enriching target validation.
 Sujets chemical biology, target validation, medicinal chemistry, small molecule, drug discovery, target-phenotype relationship, structural biology, chemical proteomics, synthetic chemistry, chemistry, proteomics
 Page web http://www.healthtech.com/Target-Validation
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
 Sujets apparentés Biochimie et chimie médicale, toxicologie
  
14.Drug Discovery Summit
 Dates 22 Mai 2014 → 23 Mai 2014
[ID=611924] Haut de la page
 LieuCambridge, États-Unis
 Résumé We invite you to attend the Drug Discovery Summit, which will take place May 22- 23, 2014 in Cambridge, MA.
 Sujets drug, discovery, summit
 Page web http://www.gtcbio.com/component/conference/?file=home&cn=Drug+Discovery+Summit&cid=87&utm_source=drugdiscovery%2B&utm_medium=EventListing&utm_content=drugdiscovery%2B&utm_campaign=drugdiscovery%2B
 Contact Kristen Starkey ; Tél.: [626-256-6405]; Email.: infogtcbio@gtcbio.com
  
15.Drug Safety — Bridging the Divide Between Pre-clinical and Clinical Drug Safety
 Dates 01 Jui 2014 → 06 Jui 2014
[ID=586733] Haut de la page
 LieuStonehill College, Easton, MA, États-Unis
 Organisateur Gordon Research Conferences
 Page web http://www.grc.org/meetings.aspx?year=2014
 Sujets apparentés Essais cliniques
  
16.DDTWC — Drug Discovery & Therapy World Congress 2014
 Date de début16 Jui 2014
[ID=604880] Haut de la page
 LieuBoston, États-Unis
 Résumé This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss important international breakthroughs in drug discovery and new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine. A similar series of conferences has been held by the organizers in the UAE over the last several years. These events have been highly successful and many top international scientists, including over 22 Nobel Laureates, have presented their work.
 Page web http://www.ddtwc.com/
 Contact One Boston Place; Tél.: [((+1-857-2398855))]; Email.: faizan@ddtwc.com
  
17.ddtwc — Drug Discovery and Therapy World Congress 2014
 Dates 16 Jui 2014 → 19 Jui 2014
[ID=570329] Haut de la page
 LieuBoston, États-Unis
 Résumé This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss important international breakthroughs in drug discovery and new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine. A similar series of conferences has been held by the organizers in the UAE over the last several years. These events have been highly successful and many top international scientists, including over 22 Nobel Laureates, have presented their work.
 Page web http://www.ddtwc.com/
 Contact Ms. Hasina Habib , Eureka Conference, inc ; Tél.: [+1-857-2398855]; Email.: info@ddtwc.com
  
18.Demyelination and Remyelination: From Mechanism to Therapy
 Date de début26 Jui 2014
[ID=617735] Haut de la page
 LieuNew York City, États-Unis
 Résumé This translational conference will highlight biological and clinical findings in myelin development, new techniques for brain imaging and for screening molecular targets, and novel therapeutics that promote remyelination.
 Sujets neuroimaging, MS, multiple sclerosis, white matter, neurodegeneration, neurodegenerative disease, myelin, demyelination, remyelination, myelination, stem cell, induced pluripotent stem cell, induced pluripotent stem cells, axon, MRI, PET, neuroinflammation, neuroinflammatory, oligodendrocyte, oligodendrocyte precursor, remyelinate
 Page web http://www.nyas.org/myelin2014
 Contact Tél.: [1-212-298-8640]; Email.: customerservice@nyas.org
 Sujets apparentés Neurologie; Biologie
  
19.2-day In-person Seminar on “Applied Statistics for QA, QC, Manufacturing, and Design Control” at Atlantic City NJ
 Dates 26 Jui 2014 → 27 Jui 2014
[ID=624042] Haut de la page
 LieuAtlantic City, États-Unis
 Résumé This seminar provides a practical approach to understanding how to interpret and use a standard tool-box of statistical methods, including confidence intervals, t-tests, Normal K-tables, Normality tests, confidence/reliability calculations, AQL sampling plans, measurement equipment analysis, and Statistical Process Control. Without a clear understanding and correct implementation of such methods, a company risks significantly increasing its complaint rates, scrap rates, and time-to-market; and significantly reducing its product and service quality, its customer satisfaction levels, and its profit margins.
 Sujets ISO and FDA regulations, Quality Assurance, Quality Control, MDD requirements, ComplianceOnline, Compliance Training
 Page web http://bit.ly/1fQtq98
 Contact John Robinson ; Tél.: [800-4479407]; Email.: support@globalcompliancepanel.com
 Sujets apparentés Statistique
  
20.Drug Metabolism — Integrating Drug Metabolism Sciences: From Enzymology to Systems Biology
 Dates 06 Jul 2014 → 11 Jul 2014
[ID=586779] Haut de la page
 LieuHolderness School, Holderness, NH, États-Unis
 Organisateur Gordon Research Conferences
 Page web http://www.grc.org/meetings.aspx?year=2014
 Sujets apparentés Biologie moléculaire; Biochimie et chimie médicale, toxicologie
  
21.Natural Products, A celebration and a resurrection with Reverse Pharmacology
 Dates 07 Jul 2014 → 10 Jul 2014
[ID=624088] Haut de la page
 LieuBloomingdale, États-Unis
 Page web http://www.fusion-conferences.com/conference11.php
  
22.12th VAC — 12th Vaccines Research & Development: All Things Considered Conference
 Dates 09 Jul 2014 → 11 Jul 2014
[ID=619618] Haut de la page
 LieuBoston, États-Unis
 Résumé GTC is proud to present its 12th Vaccines Research & Development: All Things Considered Conference, to be held in Boston, MA on July 9-11, 2014. This conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development, including research, product design considerations / specifications, manufacturing, regulations, investment, and policy, in a comfortable, interactive and friendly setting. It brings together the leaders in vaccinology from industry, academia, and the government for practical discussions of the future of our discipline.
 Sujets Vaccines
 Page web http://www.gtcbio.com/conference/vaccines-research-and-development-overview?utm_source=vac conference&utm_medium=website&utm_content=vac overview&utm_campaign=conference listing
 Contact Kristen Starkey ; Tél.: [(626) 256-6405]; Email.: infogtcbio@gtcbio.com
  
23.Drug Resistance — An Interdisciplinary Approach to Tackling Drug Resistance Across Disease States
 Dates 13 Jul 2014 → 18 Jul 2014
[ID=586789] Haut de la page
 LieuNewry, ME, États-Unis
 Organisateur Gordon Research Conferences
 Page web http://www.grc.org/meetings.aspx?year=2014
 Sujets apparentés Médecine (en général)
  
24.Protein Processing, Trafficking & Secretion — Gordon Research Seminar/Insight into Molecular Mechanisms, Membrane Trafficking, Folding & ER Stress, Pathology and Therapeutic Applications
 Dates 19 Jul 2014 → 20 Jul 2014
[ID=588354] Haut de la page
 LieuColby-Sawyer College, New London, NH, États-Unis
 Organisateur Gordon Research Conferences
 Page web http://www.grc.org/meetings.aspx?year=2014
 Sujets apparentés Biologie moléculaire
  
25.Protein Processing, Trafficking & Secretion — At the Crossroads of Understanding the Maturation and Transport of Proteins/Peptides and the Therapeutic Applications of Post-translational Modulation
 Dates 20 Jul 2014 → 25 Jul 2014
[ID=588366] Haut de la page
 LieuColby-Sawyer College, New London, NH, États-Unis
 Organisateur Gordon Research Conferences
 Page web http://www.grc.org/meetings.aspx?year=2014
 Sujets apparentés Biologie moléculaire
  
26.Diffraction Methods in Structural Biology — Gordon Research Seminar/Towards Integrative Structural Biology
 Dates 26 Jul 2014 → 27 Jul 2014
[ID=586696] Haut de la page
 LieuBates College, Lewiston, ME, États-Unis
 Organisateur Gordon Research Conferences
 Page web http://www.grc.org/meetings.aspx?year=2014
 Sujets apparentés Biologie moléculaire; Biologie
  
27.Diffraction Methods in Structural Biology — Faster, Smaller, Better: Novel Technologies for Diffraction Experiments in Molecular Biology and Drug Discovery
 Dates 27 Jul 2014 → 01 Aou 2014
[ID=586719] Haut de la page
 LieuBates College, Lewiston, ME, États-Unis
 Organisateur Gordon Research Conferences
 Page web http://www.grc.org/meetings.aspx?year=2014
 Sujets apparentés Biologie moléculaire; Biologie
  
28.Medicinal Chemistry — Gordon Research Seminar/Explained and Applied
 Dates 02 Aou 2014 → 03 Aou 2014
[ID=587485] Haut de la page
 LieuColby-Sawyer College, New London, NH, États-Unis
 Organisateur Gordon Research Conferences
 Page web http://www.grc.org/meetings.aspx?year=2014
 Sujets apparentés Biochimie et chimie médicale, toxicologie
  
29.Medicinal Chemistry — The Leading Edge of Drug Discovery
 Dates 03 Aou 2014 → 08 Aou 2014
[ID=587497] Haut de la page
 LieuColby-Sawyer College, New London, NH, États-Unis
 Organisateur Gordon Research Conferences
 Page web http://www.grc.org/meetings.aspx?year=2014
 Sujets apparentés Biochimie et chimie médicale, toxicologie
  
30.ECI — Biological and Pharmaceutical Complex Fluids II: Novel Trends in Characterizing Interactions, Microstructure and Rheology
 Dates 10 Aou 2014 → 14 Aou 2014
[ID=616359] Haut de la page
 LieuDurham, États-Unis
 Résumé Biotherapeutics or biologics are rapidly emerging as the next generation of therapeutic solutions for many life threatening diseases in the areas of unmet medical need. This sector is expected to continue its significant growth over the next decade as rapid development of recombinant proteins and peptides along with identification of newer targeting approaches lead to augmentation or replacement of small organic molecules with therapeutic proteins. Developing stable formulations with these biological complex fluids comes with its own set of challenges as complex specific and non-specific interactions can lead to self-association, irreversible aggregate formation, and other manifestations that negatively impact physicochemical properties and delivery. These in turn lead to issues in formulation storage stability, high viscosity and associated issues in manufacturing and injectability etc. Similar to other complex fluids, these biological complex fluids also exhibit rich interfacial and surface properties leading to structuring and interactions with air/water and solid/water interfaces.

Understanding and establishing the structure-property relationships in such systems and understanding interactions in complex biopharmaceutical formulations is, therefore, key to designing stable new therapeutic solutions and novel drug delivery mechanisms. However, most of these systems have their unique characterization challenges such as, small sample volumes, high sensitivity to any applied shear, external conditions etc. Also it is of primary importance to characterize the microstructure and interactions either in-vivo or in environments that very closely mimic the biological environment of interest. The need to characterize such complex fluids/soft matter systems also extends to other industrial sectors such as foods and some of the characterization challenges and limitations of current techniques remain quite similar across biopharmaceuticals & foods.

 Sujets •Conformational and Colloidal Stability •Charge and Electrostatic Interactions •Protein-Protein Interactions •Protein Aggregation-Thermodynamics, Kinetics & Interactions •Protein Rheology and Microrheology in Bulk •Protein Structuring and Rheology at Interfaces •Micro/mesostructure in Self-Associated Biological Complex Fluids I
 Page web http://www.engconf.org/conferences/biotechnology/biological-and-pharmaceutical-complex-fluids-ii-novel-trends-in-characterizing-interactions-microstructure-and-rheology/
 Contact Arlene Conway ; Tél.: [12125146760]; Email.: arlene@engconfintl.org
 Sujets apparentés Physique appliquée: Mécanique, tribologie et rhéologie; Biologie
  
31.ImVacS: The Immunotherapies and Vaccines Summit
 Dates 11 Aou 2014 → 13 Aou 2014
[ID=614623] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé ImVacS, The Immunotherapies and Vaccine Summit, brings together a global audience of vaccine researchers and developers of cancer immunotherapies for four focused meetings that explore the frontiers of immunology as the basis for patient treatment.

Part 1 of the 9th annual "Novel Vaccines" meeting addresses "Adjuvants, TLRs and DNA Vaccines," while Part 2 explores "Emerging Vaccine Technologies." The 2nd annual "Immunomodulatory Therapeutic Antibodies for Cancer" meeting examines developments in the models and tools used in developing these emerging drug products, while the inaugural "Combination Cancer Immunotherapy" meeting focuses on the application of these antibody programs in combination with other treatment modalities. Target Discovery for T Cell Therapy Symposium will bring together leading academic and industry researchers to discuss how to find and validate suitable targets and antigens for t cell therapies.

 Sujets vaccine, immunotherapies, immunology, t cell, cancer, adjuvant, tlr, antibody, therapeutic antibodies, therapeutics
 Page web http://www.imvacs.com
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
  
32.Drug Carriers in Medicine & Biology — Gordon-Merck Research Seminar
 Dates 16 Aou 2014 → 17 Aou 2014
[ID=586670] Haut de la page
 LieuWaterville Valley, NH, États-Unis
 Organisateur Gordon Research Conferences
 Page web http://www.grc.org/meetings.aspx?year=2014
 Sujets apparentés Biologie moléculaire
  
33.Drug Carriers in Medicine & Biology — Leveraging Mechanism and Chemical Design for Improved Therapeutic Effect
 Dates 17 Aou 2014 → 22 Aou 2014
[ID=586660] Haut de la page
 LieuWaterville Valley, NH, États-Unis
 Organisateur Gordon Research Conferences
 Page web http://www.grc.org/meetings.aspx?year=2014
 Sujets apparentés Biologie moléculaire
  
34.Regulatory Affairs — 4th International Conference on Pharmaceutical Regulatory Affairs
 Dates 08 Sep 2014 → 10 Sep 2014
[ID=610705] Haut de la page
 LieuNorth Carolina, États-Unis
 Page web http://regulatoryaffairs2014.pharmaceuticalconferences.com/
 Contact Kasper Dave; Tél.: [1-650-268-9744]; Email.: regulatoryaffairs2014@omicsgroup.us
  
35.Polymers in Drug Delivery
 Dates 16 Sep 2014 → 17 Sep 2014
[ID=612359] Haut de la page
 LieuPhiladelphia, États-Unis
 Résumé The event focuses on parenteral drug administration (PDA), i.e. non-oral routes of pharmaceutical delivery including pre-filled syringes, bags, tubes, inhalers, and implants that leach active ingredients.
 Page web http://www.amiplastics-na.com/events/Event.aspx?code=C613&sec=4246
 Contact Stephanie Berchem; Tél.: [610 478 0800]; Email.: sb@amiplastics-na.com
 Sujets apparentés Chimie organique et polymères
  
36.Orphan Drugs — Orphan Drugs, Collaborations & Market Access Congress
 Dates 29 Sep 2014 → 30 Sep 2014
[ID=612951] Haut de la page
 LieuSan Diego, États-Unis
 Résumé The congress will bring together investors and experts in the orphan drug and rare disease space to share innovative research and best practice approaches to issues in R&D, clinical development, market access, pricing and reimbursement. Through an expert speaker panel, interactive forums, and a vibrant exhibition area, the meeting hopes to create long-lasting partnerships and solutions that help to address both the 7,000 rare diseases afflicting patients, market access challenges and opportunities and the financial implications of working in this field.
 Sujets Orphan Drugs, drug, discovery, R & D, research, market access, therapies, patient, investment, venture capital
 Page web http://www.globalengage.co.uk/orphan-drugs.html
 Contact Tél.: [0186 584 9841]; Email.: nnoakes@globalengage.co.uk
  
37.BABE-2014 — 5th World Congress on Bioavailabity and Bioequivalence: Pharmaceutical R&D Summit
 Dates 29 Sep 2014 → 01 Oct 2014
[ID=605023] Haut de la page
 LieuBaltimore, États-Unis
 Résumé BABE-2014 is a scientific avenue for people from diversified Pharmaceutical backgrounds, Academic Institutions, Healthcare Institutes, Pharmaceutical Regulatory Agencies, Biotech and Clinical Research Organizations making the congress a desirable platform where participants can communicate and mutually get benefited by sharing experiences about their respective fields of interest, build collaborations with research organizations, acquire benefits from interactive workshops, promote innovative styles, trends and advancements of Bioavailability and Bioequivalence.
 Page web http://babe2014.pharmaceuticalconferences.com/
 Contact John Benson , BABE-2014 Organizing Committee ; Tél.: [1-888-843-8169]; Email.: babe2014@omicsonline.us
  
38.The 5th Asia Clinical Triials Outsourcing Congress
 Dates 09 Oct 2014 → 10 Oct 2014
[ID=599481] Haut de la page
 LieuSan Diego, États-Unis
 Résumé This conference combines the previously independent China Clinical Trials Outsourcing Congress and Asia Clinical Trials Outsourcing Congress to address the subjects relevant to the region in a more coherent way. It is also co-located with the Asia Pharma R&D Outsourcing Congress which will look at the growing trend towards conducting earlier phases of discovery and pre-clinical studies in Asia.
 Sujets Clinical Trials, CROS, Pharmacovigilence, Outsourcing
 Page web http://www.clinical-trials-events.com/asia.html
 Contact Nick Noakes; Tél.: [+44 (0) 1865 849841]; Email.: nnoakes@globalengage.co.uk
 Sujets apparentés Essais cliniques
  
39.MedicReS 4th World Congress on Good Medical Research
 Dates 16 Oct 2014 → 18 Oct 2014
[ID=575465] Haut de la page
 LieuNew York, États-Unis
 Page web http://www.medicres.org
 Contact Burak AKICIER; Email.: info@medicres.org
 Sujets apparentés Médecine (en général)
  
40.VACC14 — 8th Vaccine & ISV Congress
 Dates 26 Oct 2014 → 28 Oct 2014
[ID=612952] Haut de la page
 LieuPhiladelphia, États-Unis
 Résumé Join us in Philadelphia for the premier conference on vaccines and vaccination. The 8th Vaccine & ISV Congress will feature science and public health topics, from primary vaccine research and vaccine manufacturers, to governmental policy, safety and regulation. If you work as a researcher in vaccine-related topics, in the vaccine industry, or in vaccine policy making, this is your must-attend event in 2014.
 Sujets Human vaccines - infectious diseases, Human vaccines - non-infectious diseases, Veterinary vaccines, Vaccine safety, Clinical studies and field trials, Immunology, animal models, Vectors, adjuvants, drug delivery, Production, manufacturing, Regulatory, societal, economic, programmatic, legislation subjects
 Page web http://www.vaccinecongress.com/
  
41.CHEMOTHERAPY FOUNDATION SYMPOSIUM: Innovative Cancer Therapy for Tomorrow®
 Dates 05 Nov 2014 → 07 Nov 2014
[ID=623177] Haut de la page
 LieuNew York, États-Unis
 Résumé CHEMOTHERAPY FOUNDATION SYMPOSIUM, Innovative Cancer Therapy for Tomorrow®, is a CME accredited educational activity jointly presented by the Icahn School of Medicine at Mount Sinai and the Chemotherapy Foundation, a non-profit organization supporting cancer research, in collaboration with The Tisch Cancer Institute. Founded in 1972 by Ezra Greenspan, we continue to bring the groundbreaking advances spearheading progress in cancer therapeutics to community and academic practitioners. Leading oncologist and hematologist investigators will report on new regimens, clinical trials and emerging therapeutic advances in common cancer types.
 Sujets Cancer, Chemotherapy, Oncology, Hematology, Breast Cancer, Gynecological Oncology, Surgical Oncologists, Pediatric Oncology, Radiotherapy, Immunology, Oncology Nurses, Case Managers, Pharmacists
 Page web http://www.chemotherapyfoundationsymposium.org/CMS/
 Contact Tél.: [212 866 2813]; Email.: Jaclyn.silverman@mssm.edu
 Sujets apparentés Cancérologie; Hématologie
  
42.Clinical Pharmacy-2014 — 2nd International Summit on Clinical Pharmacy
 Dates 02 Dec 2014 → 03 Dec 2014
[ID=613061] Haut de la page
 LieuSan Francisco, États-Unis
 Résumé Clinical Pharmacy-2014 is a unique event which forms a network with leading pharmacy doctors, researchers, industry professionals, scientists, pharmacists and scholar students to exchange and share their experiences, new ideas and research results about all aspects of Clinical Pharmacy and to discuss the practical challenges encountered and the solutions adopted.

2nd International Summit on Clinical Pharmacy provides opportunities for the delegates to exchange new ideas and new application experiences directly, to establish research relations and to find global partners for future collaboration. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies about Clinical Pharmacy. By attending this prestigious event you will be enlightened with innovative ideas and solutions and take initiatives to find better education in the biomedical, pharmaceutical, sociobehavioral and clinical sciences.

 Sujets General Clinical Pharmacology, Pharmacists Role in Patient Safety, Clinical Pharmacy and Its Key Role in Treatment, Dispensing Pharmacy and Research Chemists
 Page web http://clinicalpharmacy2014.pharmaceuticalconferences.com/index.php
 Contact Tél.: [1-650-268-9744]; Email.: clinicalpharmacy2014@omicsgroup.us
  

États-Unis: liste de tous les évènements/conférences.

Dernière mise à jour: 22 avril 2014